News & Perspective

Feb 29, 2008

Feb 29, 2008

Judge dismisses suit to limit DoD anthrax vaccinations

(CIDRAP News) – A federal district judge has dismissed a lawsuit aiming to stop the Pentagon's mandatory anthrax vaccination program for troops serving in some areas overseas, the Associated Press (AP) reported today.

Judge Rosemary M. Collyer in Washington, DC, said the Food and Drug Administration (FDA) acted appropriately when it determined the vaccine was safe and approved its use, according to the AP.

Mar 07, 2008

Mar 07, 2008

CDC retires one old smallpox vaccine, keeps another

(CIDRAP News) – Federal health officials recently announced plans to get rid of their last remaining stocks of the decades-old smallpox vaccine Dryvax, as a newer vaccine takes its place in the national stockpile of emergency medical supplies.

May 02, 2008

May 02, 2008

Researchers find fast way to make human antibodies against flu

(CIDRAP News) – Technical barriers have prevented the widespread use of human monoclonal antibodies as potent diagnostic and treatment tools, but scientists now say they have found a way to produce antibodies against seasonal influenza much faster than was previously possible.

May 20, 2008

May 20, 2008

FDA approves levofloxacin for anthrax in children

(CIDRAP News) – The US Food and Drug Administration (FDA) recently offered another antibiotic option for combating inhalational anthrax in children by approving the quinolone drug levofloxacin (Levaquin).

In a letter dated May 5, the FDA endorsed the use of levofloxacin, made by Ortho-McNeil, in children 6 months of age and older. The agency had approved use of the drug for postexposure treatment of anthrax in adults in 2004.

Aug 12, 2008

Aug 12, 2008

HHS evaluates proposals for new anthrax vaccine

(CIDRAP News) – Two Maryland pharmaceutical companies recently announced that they have submitted proposals to produce and deliver at least 25 million doses of a next-generation anthrax vaccine to the nation's Strategic National Stockpile.

Sep 09, 2008

Sep 09, 2008

HHS funds work on new anthrax antitoxin

(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.

Oct 02, 2008

Oct 02, 2008

To blunt anthrax attack, mail carriers to get antibiotics

(CIDRAP News) – Federal health officials yesterday announced a plan to supply mail carriers with antibiotics so they will be protected and prepared to deliver the drugs to others in case of an anthrax attack.

The program will start with a $500,000 pilot project involving carriers in Minneapolis and St. Paul, which were chosen because of their extensive bioterrorism preparations, according to an Associated Press (AP) report yesterday.

Dec 22, 2008

Dec 22, 2008

FDA approves shortened anthrax-vaccine course

(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»